Shoulder Innovations, Inc. (SI) AI Stock Analysis

• Market Cap: $246.56M
• Dividend Yield: N/A
• Average Volume (3M): 132.78K
• Price to Earnings (P/E): ―
• Beta (1Y): -1.12
• Revenue Growth: 39.77%
• EPS Growth: -122.70%
• Country: US
• Employees: 300
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Specialties
• EPS (TTM): N/A
• Shares Outstanding: 20,359,960
• 10 Day Avg. Volume: 65,235
• 30 Day Avg. Volume: 132,779
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $17.39
• Price Target Upside: 43.60% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 6

• Rating: 41 Neutral
• Price Target: $11.50 ▼(-5.04% Downside)

The overall stock score for Shoulder Innovations, Inc. is primarily impacted by its financial performance, which shows revenue growth but significant profitability and cash flow challenges. Technical analysis indicates bearish momentum, and the valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively suggest caution for potential investors.

Positive Factors

Revenue Growth

Strong revenue growth indicates successful market penetration and increasing demand for SI's orthopedic solutions, supporting long-term expansion.

Business Model

The direct sales model, combined with strategic partnerships, enhances market reach and customer engagement, fostering sustainable revenue streams.

Product Innovation

SI's focus on innovative products for minimally invasive procedures positions it as a leader in orthopedic solutions, driving competitive advantage.

Negative Factors

Profitability Challenges

Ongoing profitability challenges, with negative margins, could hinder reinvestment and growth, impacting long-term financial health.

Cash Flow Issues

Negative operational cash flow raises concerns about liquidity and the ability to fund operations without external financing.

Increased Leverage

Rising leverage could strain financial flexibility and increase risk, especially if revenue growth does not translate into improved profitability.

Shoulder Innovations, Inc. Business Overview & Revenue Model

Company Description

Shoulder Innovations, Inc. (SI) is a medical technology company specializing in the development and commercialization of advanced orthopedic solutions specifically for shoulder surgeries. The company focuses on creating innovative surgical instruments and implants that improve patient outcomes and enhance surgical efficiency. Operating within the healthcare sector, SI aims to revolutionize shoulder surgery through its cutting-edge products that are designed for minimally invasive procedures.

How the Company Makes Money

Shoulder Innovations, Inc. generates revenue primarily through the sale of its orthopedic surgical products, including implants and instruments used in shoulder surgeries. The company utilizes a direct sales model, partnering with hospitals, surgical centers, and orthopedic surgeons to provide its products. Additionally, SI may engage in strategic partnerships with larger medical device companies to expand its distribution channels and market reach. Revenue is also supplemented through training programs for surgical staff and ongoing support services, ensuring that healthcare providers are well equipped to use SI's products effectively.

Shoulder Innovations, Inc. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	Dec 2024	Dec 2023
Income Statement
Total Revenue	31.62M	19.27M
Gross Profit	24.34M	15.27M
EBITDA	-12.76M	-9.52M
Net Income	-15.62M	-12.65M
Balance Sheet
Total Assets	43.08M	54.29M
Cash, Cash Equivalents and Short-Term Investments	15.04M	32.81M
Total Debt	14.73M	14.46M
Total Liabilities	22.33M	18.70M
Stockholders Equity	20.75M	35.59M
Cash Flow
Free Cash Flow	-18.16M	-15.89M
Operating Cash Flow	-14.14M	-13.14M
Investing Cash Flow	13.96M	-28.97M
Financing Cash Flow	66.00K	44.73M

Shoulder Innovations, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MMSI	79 Outperform	$4.77B	40.88	8.60%	―	10.14%	0.04%
VCEL	71 Outperform	$1.69B	269.37	2.59%	―	16.13%	670.90%
LMAT	71 Outperform	$1.93B	41.43	13.81%	0.87%	14.11%	23.98%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ATEC	49 Neutral	$2.07B	―	-376.89%	―	26.27%	15.58%
ICUI	49 Neutral	$2.87B	―	-1.78%	―	2.95%	47.92%
SI	41 Neutral	$246.56M	―	―	―	39.77%	-122.70%